224 related articles for article (PubMed ID: 22586115)
1. Peptidomics approach to elucidate the proteolytic regulation of bioactive peptides.
Kim YG; Lone AM; Nolte WM; Saghatelian A
Proc Natl Acad Sci U S A; 2012 May; 109(22):8523-7. PubMed ID: 22586115
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the proteolysis of bioactive peptides using a peptidomics approach.
Kim YG; Lone AM; Saghatelian A
Nat Protoc; 2013 Sep; 8(9):1730-42. PubMed ID: 23949379
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis for the recognition and cleavages of IGF-II, TGF-alpha, and amylin by human insulin-degrading enzyme.
Guo Q; Manolopoulou M; Bian Y; Schilling AB; Tang WJ
J Mol Biol; 2010 Jan; 395(2):430-43. PubMed ID: 19896952
[TBL] [Abstract][Full Text] [Related]
4. Degradation of Alzheimer's Amyloid-β by a Catalytically Inactive Insulin-Degrading Enzyme.
Sahoo BR; Panda PK; Liang W; Tang WJ; Ahuja R; Ramamoorthy A
J Mol Biol; 2021 Jun; 433(13):166993. PubMed ID: 33865867
[TBL] [Abstract][Full Text] [Related]
5. Peptidomics of prolyl endopeptidase in the central nervous system.
Nolte WM; Tagore DM; Lane WS; Saghatelian A
Biochemistry; 2009 Dec; 48(50):11971-81. PubMed ID: 19911840
[TBL] [Abstract][Full Text] [Related]
6. IDE Degrades Nociceptin/Orphanin FQ through an Insulin Regulated Mechanism.
Zingale GA; Bellia F; Ahmed IMM; Mielczarek P; Silberring J; Grasso G
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31509943
[TBL] [Abstract][Full Text] [Related]
7. Somatostatin: a novel substrate and a modulator of insulin-degrading enzyme activity.
Ciaccio C; Tundo GR; Grasso G; Spoto G; Marasco D; Ruvo M; Gioia M; Rizzarelli E; Coletta M
J Mol Biol; 2009 Feb; 385(5):1556-67. PubMed ID: 19073193
[TBL] [Abstract][Full Text] [Related]
8. The proteolytic activity of insulin-degrading enzyme: a mass spectrometry study.
Grasso G; Rizzarelli E; Spoto G
J Mass Spectrom; 2009 May; 44(5):735-41. PubMed ID: 19127548
[TBL] [Abstract][Full Text] [Related]
9. Yeast as a tractable genetic system for functional studies of the insulin-degrading enzyme.
Kim S; Lapham AN; Freedman CG; Reed TL; Schmidt WK
J Biol Chem; 2005 Jul; 280(30):27481-90. PubMed ID: 15944156
[TBL] [Abstract][Full Text] [Related]
10. Peptidomics methods for the identification of peptidase-substrate interactions.
Lone AM; Kim YG; Saghatelian A
Curr Opin Chem Biol; 2013 Feb; 17(1):83-9. PubMed ID: 23332665
[TBL] [Abstract][Full Text] [Related]
11. Colon tumour secretopeptidome: insights into endogenous proteolytic cleavage events in the colon tumour microenvironment.
Greening DW; Kapp EA; Ji H; Speed TP; Simpson RJ
Biochim Biophys Acta; 2013 Nov; 1834(11):2396-407. PubMed ID: 23684732
[TBL] [Abstract][Full Text] [Related]
12. Molecular basis of catalytic chamber-assisted unfolding and cleavage of human insulin by human insulin-degrading enzyme.
Manolopoulou M; Guo Q; Malito E; Schilling AB; Tang WJ
J Biol Chem; 2009 May; 284(21):14177-88. PubMed ID: 19321446
[TBL] [Abstract][Full Text] [Related]
13. AP/MALDI-MS complete characterization of the proteolytic fragments produced by the interaction of insulin degrading enzyme with bovine insulin.
Grasso G; Rizzarelli E; Spoto G
J Mass Spectrom; 2007 Dec; 42(12):1590-8. PubMed ID: 18085545
[TBL] [Abstract][Full Text] [Related]
14. Molecular bases for the recognition of short peptide substrates and cysteine-directed modifications of human insulin-degrading enzyme.
Malito E; Ralat LA; Manolopoulou M; Tsay JL; Wadlington NL; Tang WJ
Biochemistry; 2008 Dec; 47(48):12822-34. PubMed ID: 18986166
[TBL] [Abstract][Full Text] [Related]
15. Constrained analogues of the calcitonin gene-related peptide.
Hakala JM; Valo T; Vihavainen S; Hermonen J; Heino P; Halme M; Koskinen AM
Biochem Biophys Res Commun; 1994 Jul; 202(1):497-503. PubMed ID: 8037754
[TBL] [Abstract][Full Text] [Related]
16. Proteolytic fragments of insulysin (IDE) retain substrate binding but lose allosteric regulation.
Song ES; Cady C; Fried MG; Hersh LB
Biochemistry; 2006 Dec; 45(50):15085-91. PubMed ID: 17154546
[TBL] [Abstract][Full Text] [Related]
17. Structure based discovery of small molecules to regulate the activity of human insulin degrading enzyme.
Çakir B; Dağliyan O; Dağyildiz E; Bariş İ; Kavakli IH; Kizilel S; Türkay M
PLoS One; 2012; 7(2):e31787. PubMed ID: 22355395
[TBL] [Abstract][Full Text] [Related]
18. Investigating endogenous peptides and peptidases using peptidomics.
Tinoco AD; Saghatelian A
Biochemistry; 2011 Sep; 50(35):7447-61. PubMed ID: 21786763
[TBL] [Abstract][Full Text] [Related]
19. Turn structures in CGRP C-terminal analogues promote stable arrangements of key residue side chains.
Carpenter KA; Schmidt R; von Mentzer B; Haglund U; Roberts E; Walpole C
Biochemistry; 2001 Jul; 40(28):8317-25. PubMed ID: 11444978
[TBL] [Abstract][Full Text] [Related]
20. Cellular localization of neprilysin in mouse bone tissue and putative role in hydrolysis of osteogenic peptides.
Ruchon AF; Marcinkiewicz M; Ellefsen K; Basak A; Aubin J; Crine P; Boileau G
J Bone Miner Res; 2000 Jul; 15(7):1266-74. PubMed ID: 10893675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
